Surgical Considerations in Advance Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and Cutaneous Melanoma: a Head and Neck Perspective

被引:0
作者
Zhou T.C. [1 ]
Eskander A.E. [2 ]
Old M.O. [1 ,3 ]
Kang S.Y. [1 ,3 ]
Teknos T.N. [4 ,5 ]
机构
[1] Department of Otolaryngology – Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH
[2] Department of Otolaryngology – Head and Neck Surgery, University of Toronto, Toronto, ON
[3] Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
[4] Department of Otolaryngology – Head and Neck Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside 1071, Cleveland, 44106, OH
[5] Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland, OH
关键词
Basal cell carcinoma; Head and neck; Melanoma; Review; Squamous cell carcinoma; Surgery;
D O I
10.1007/s40136-018-0195-3
中图分类号
学科分类号
摘要
Purpose of Review: Skin cancers, including basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous melanoma, are the most common cancer worldwide. The treatment of these cancers is primarily surgical, and when treated early and correctly, the prognosis is excellent. In this review, we aim to discuss the appropriate surgical management of skin cancers and associated controversies as it pertains to the head and neck. Recent Findings: Evidences guiding treatment have expanded enormously over the past decade. Studies have drastically improved our understanding of skin cancer including risk factors for tumor recurrence and metastasis, indicated margin size of surgical excision, the role of sentinel lymph node biopsy, and the management of occult and gross regional neck metastasis. Summary: Management of skin cancer poses a unique challenge in the head and neck region due to its proximity to anatomic sensitive areas and complex lymphatic drainage. Understanding how to efficiently manage the primary tumor site and the regional lymph nodes is paramount in minimizing locoregional recurrence and improving overall survival. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:140 / 150
页数:10
相关论文
共 97 条
[1]  
Rogers H.W., Weinstock M.A., Feldman S.R., Coldiron B.M., Incidence estimate of nonmelanoma skin Cancer (keratinocyte carcinomas) in the U.S. population, 2012, JAMA Dermatol, 151, pp. 1081-1086, (2015)
[2]  
Gloster H.M., Neal K., Skin cancer in skin of color, J Am Acad Dermatol, 55, pp. 741-760, (2006)
[3]  
Staples M., Marks R., Giles G., Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?, Int J Cancer, 78, pp. 144-148, (1998)
[4]  
Nestor M.S., Zarraga M.B., The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida, J Clin Aesthetic Dermatol, 5, pp. 20-24, (2012)
[5]  
Cancer Stat Facts: Melanoma of the Skin, (2018)
[6]  
Cancer Facts & Figures 2018 [Internet]
[7]  
Miller D.L., Weinstock M.A., Nonmelanoma skin cancer in the United States: incidence, J Am Acad Dermatol, 30, pp. 774-778, (1994)
[8]  
Rubin A.I., Chen E.H., Ratner D., Basal-cell carcinoma, N Engl J Med, 353, pp. 2262-2269, (2005)
[9]  
McCusker M., Basset-Seguin N., Dummer R., Lewis K., Schadendorf D., Sekulic A., Et al., Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease, Eur J Cancer, 50, pp. 774-783, (2014)
[10]  
Basal cell skin cancer (Version 1.2018) [Internet]. NCCN Clnical Practice Guidelines in Oncology, National Comprehensive Cancer Network Guidelines on Management of Basal Cell Carcinoma, (2018)